Want to see VERA full AI Analyst Report?
Atacicept
Iga Nephropathy (Igan), Berger Disease
Phase II
Recruiting
Monthly Dosing of Atacicept in IgAN
May 13, 2025
―
Atacicept
Fsgs, Igan, Pmn, Nephrotic Syndrome, Mcd
Phase II
Recruiting
Atacicept in Multiple Glomerular Diseases
May 13, 2025
―
Atacicept 150 Mg
Iga Nephropathy (Igan), Berger Disease, Renal And Urinary Disorders
Phase II
Enrolling By Invitation
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
Oct 03, 2024
―
Atacicept
Lupus Nephritis (Ln)
Phase III
Withdrawn
Atacicept in Subjects With Active Lupus Nephritis (COMPASS)
Nov 02, 2022
―
Atacicept
Iga Nephropathy, Berger Disease
Phase III
Active Not Recruiting
Atacicept in Subjects With IgA Nephropathy
Jan 11, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Vera Therapeutics (VERA) have in its pipeline
VERA is currently developing the following drugs: Atacicept, Atacicept, Atacicept 150 Mg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.